The two most common aberrations enriched at the AML stage in SF3B1‐mutated patients are EVI1 (inversion or translocation of chromosome 3 – Inv3/t(3,3)) and RUNX1 mutations45, 63, 67 (Figure 3). This evidence concerns the gene SF3B1 and acute myeloid leukemia.